SelectScience InterviewsLife Sciences
Multi-modality approach to predicting and monitoring immunotherapy response and resistance
18 May 2021
Watch this keynote presentation by, Dr. Genevieve Boland, Assistant Professor, Harvard Medical School, titled: Multi-modality approach to predicting and monitoring immunotherapy response and resistance. This talk was presented at the SelectScience® Virtual Cancer and Immunology Research Summit 2021.
About the company
SelectScience
Established in July 1998, SelectScience is the fastest way to impartial, expert opinion about the best laboratory equipment and latest techniques.
